EcoDrugPlus

Protein Kinase D1

Ensembl ID : ENSBSLG00000007349
Gene Symbol: PRKD1
2 Cross references
210 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSBSLG00000026106
Gene Symbol: PRKD3
3 Cross references
218 Possible Orthologues:

Protein Kinase D3

Ensembl ID : ENSBSLG00000011152
Gene Symbol: PRKD3
3 Cross references
207 Possible Orthologues:

Protein Phosphatase 3 Catalytic Subunit Alpha

Ensembl ID : ENSBSLG00000000319
Gene Symbol: PPP3CA
3 Cross references
233 Possible Orthologues:

Protein Tyrosine Kinase 2

Ensembl ID : ENSBSLG00000010100
Gene Symbol: PTK2
3 Cross references
241 Possible Orthologues:

Protein Tyrosine Kinase 2 Beta

Ensembl ID : ENSBSLG00000005909
Gene Symbol: PTK2B
3 Cross references
196 Possible Orthologues:

Protein Tyrosine Phosphatase Non-Receptor Type 11

Ensembl ID : ENSBSLG00000012018
Gene Symbol: PTPN11
3 Cross references
253 Possible Orthologues:

Protein Tyrosine Phosphatase Receptor Type B

Ensembl ID : ENSBSLG00000013010
Gene Symbol: PTPRB
3 Cross references
193 Possible Orthologues:

Protein-Serine O-Palmitoleoyltransferase Porcupine-Like

Ensembl ID : ENSBSLG00000024456
Gene Symbol: LOC114859378
3 Cross references
197 Possible Orthologues:

Proteinase-Activated Receptor 1-Like

Ensembl ID : ENSBSLG00000008727
Gene Symbol: LOC114867200
3 Cross references
265 Possible Orthologues:

Proto-Oncogene Tyrosine-Protein Kinase Src

Ensembl ID : ENSBSLG00000022205
Gene Symbol: LOC114858580
3 Cross references
198 Possible Orthologues:

Purinergic Receptor P2x 3

Ensembl ID : ENSBSLG00000021429
Gene Symbol: P2RX3
3 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).